KIR-LIGAND mismatched natural killer cells effectively kill primary myeloma and myeloma cell lines.

被引：0
|
作者：
van Rhee, F
Szmania, SM
Shi, JM
Cottler-Fox, M
Dyniewski, JW
Tricot, GJ
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2449
引用
收藏
页码：672A / 673A
页数：2
相关论文
共 50 条
  • [1] Killer immunoglobulin-like receptor ligand (KIR-L) mismatched natural killer (NK) cells for relapsed myeloma
    van Rhee, F
    Shi, J
    Szmania, S
    Rosen, N
    Moreno, A
    Walker, R
    Dupont, B
    Hsu, K
    Baxter-Lowe, LA
    Campana, D
    Barlogie, B
    Cottler-Fox, M
    Tricot, G
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 618 - 619
  • [2] Immunotherapy with haplo-identical KIR-ligand mismatched natural killer cells in the setting of autologous transplantation.
    Szmania, SM
    Smith, S
    Bennett, G
    Batchu, RB
    Barlogie, B
    Cottler-Fox, MH
    Tricot, G
    van Rhee, F
    BLOOD, 2003, 102 (11) : 399B - 399B
  • [3] IMPACT OF KIR-LIGAND AND KIR-GENE EXPRESSION ON NK CELLS MEDIATED KILLING OF MYELOMA CELLS
    Stuebig, T.
    Hildebrandt, Y.
    Jungk, K.
    Konielski, A.
    Lange, L.
    Binder, T.
    Duske, H.
    Atanackovic, D.
    Fehse, B.
    Eiermann, T.
    Zander, A.
    Kroeger, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 308 - 308
  • [4] Killer immunoglobulin-like receptor ligand (KIR-lig) mismatched natural killer (NK) cell transfusions for multiple myeloma (MM).
    Shi, J
    Szmania, S
    Rosen, N
    Moreno, A
    Walker, R
    DuPont, B
    Hsu, K
    Baxter-Lowe, LA
    Shaughnessy, J
    Barlogie, B
    Cottler-Fox, M
    Tricot, G
    van Rhee, F
    BLOOD, 2005, 106 (11) : 969A - 969A
  • [5] Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
    Swift, Brenna E.
    Williams, Brent A.
    Kosaka, Yoko
    Wang, Xing-Hua
    Medin, Jeffrey A.
    Viswanathan, Sowmya
    Martinez-Lopez, Joaquin
    Keating, Armand
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07): : 1020 - 1028
  • [6] Autologous Activated and Expanded Natural Killer Cells Kill Clonogenic Myeloma Cells: A New Therapeutic Option for Multiple Myeloma
    Leivas, Alejandra
    Risueno, Ruth M.
    Perez-Martinez, Antonio
    Jesus Blanchard, Mara
    Campana, Dario
    Jose Lahuerta, Juan
    Martinez-Lopez, Joaqun
    BLOOD, 2014, 124 (21)
  • [7] IL-6 down-regulates CD33 expression in primary myeloma cells as well as myeloma cell lines.
    Shamsasenjan, Karim
    Abroun, Saeid
    Liu, Shngqin
    Amin, Jakia
    Islam, Khademul
    Otsuyama, Ken-ichiro
    Kawano, Michio M.
    BLOOD, 2006, 108 (11) : 340B - 341B
  • [8] Ex Vivo Activated Natural Killer (NK) Cells from Myeloma Patients Kill Autologous Myeloma and Killing Is Enhanced by Elotuzumab
    Garg, Tarun K.
    Szmania, Susann
    Shi, Jumei
    Stone, Katie
    Moreno-Bost, Amberly
    Malbrough, Paul
    Campana, Dario
    Barlogie, Bart
    Afar, Daniel
    van Rhee, Frits
    BLOOD, 2008, 112 (11) : 1256 - 1256
  • [9] Conserved and Unique Pathways of Natural Killer Cell Resistance in Multiple Myeloma Cell Lines
    Merino, Aimee
    Mitra, Amit
    Davis, Zachary
    Miller, Ben
    Valamehr, Bob
    Goodridge, Jode
    Miller, Jeffrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S73 - S73
  • [10] Valproic acid induces non apoptotic cell death in myeloma cells and cell lines.
    Schwartz, C
    Palissot, V
    Brons, RI
    Leners, B
    Bosseler, M
    Dicato, MA
    Berchem, GJ
    BLOOD, 2005, 106 (11) : 365B - 366B
12345